Comment on

• Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

  Donskov F, Xie W, Overby A, Wells JC, Fraccon AP, Sacco CS, Porta C, Stukalin I, Lee JL, Koutsoukos K, Yuasa T, Davis ID, Pezaro C, Kanesvaran R, Bjarnason GA, Sim HW, Rathi N, Kollmannsberger CK, Canil CM, Choueiri TK, Heng DYC. Donskov F, et al. Eur Urol Oncol. 2020 Aug;3(4):530-539. doi: 10.1016/j.euo.2020.01.001. Epub 2020 Feb 6. Eur Urol Oncol. 2020. PMID: 32037304
• How to Select the Optimal Candidates for Renal Mass Biopsy.

  Martini A, Larcher A, Bravi CA, Capogrosso P, Falagario UG, Fallara G, Pellegrino F, Muttin F, Re C, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U; Young Academic Urologists working groups on robotic surgery and kidney cancer of the European Association of Urology. Martini A, et al. Eur Urol Oncol. 2021 Jun;4(3):506-509. doi: 10.1016/j.euo.2020.10.001. Epub 2020 Oct 21. Eur Urol Oncol. 2021. PMID: 34074486